Test Price
650 AED✅ Home Collection Available
Goodpasture’s Syndrome Panel in UAE | 650 AED | 2026 DHA Guidelines
تحليل متلازمة غودباستشر في الإمارات | 650 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport; VIP Mobile Phlebotomy available.
Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by DHA-licensed specialists.
Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
تحليل معتمد ومتقدم للكشف عن الأجسام المضادة للغشاء القاعدي الكبيبي باستخدام تقنيتي ELISA والتألق المناعي غير المباشر (IFA) بأعلى معايير الجودة.
Clinical Overview & Test Comparison
Goodpasture’s Syndrome Panel is a serological that detects circulating anti‑glomerular basement membrane (anti‑GBM) antibodies, primarily IgG, aiding the rapid diagnosis of anti‑GBM disease – a life‑threatening condition affecting kidneys and lungs. يكشف تحليل متلازمة غودباستشر عن الأجسام المضادة ذاتية المناعة للغشاء القاعدي الكبيبي، وهو ضروري للتشخيص والتدخل المبكر.
| Feature | Our Goodpasture’s Panel | Closest Alternative (Routine Labs) |
|---|---|---|
| Methodology | Enzyme Immunoassay (ELISA) with Indirect Immunofluorescence (IFA) confirmation | Single ELISA or qualitative immunoblot |
| Diagnostic Sensitivity | 99.9% (ISO‑verified combination) | ~92–95% (standalone ELISA) |
| Turnaround Time | Next working day (Mon/Wed sample by 9 AM) | 3–5 working days |
| Cost | 650 AED (transparent, all‑inclusive) | 800–950 AED (hidden add‑ons) |
| Regulatory Compliance | UAE Federal Decree‑Law No. 41/2024, DHA/MOHAP Standards, ISO 9001:2015 | Often minimal external audit |
Physician Insight & Safety Protocol
“Goodpasture’s syndrome is a clinical emergency where every hour counts; anti‑GBM antibody testing is the cornerstone of diagnosis. I strongly advise correlating laboratory results with renal biopsy and pulmonary imaging, and never delay treatment while waiting for reports. This panel, performed with dual‑method confirmation, gives clinicians the confidence to initiate life‑saving plasmapheresis promptly.”
— Dr. PRABHAKAR REDDY, Nephrology & Autoimmune Specialist, DHA License 61713011
⚠️ Medication Advisory:
Do not discontinue any prescribed immunosuppressive, antihypertensive, or respiratory medication without explicit instruction from your treating physician.
Patient Safety Exclusion Criteria
- Active systemic infection or febrile illness within 48 hours.
- Recent organ transplant with ongoing immunosuppressive induction.
- Known hypersensitivity to phlebotomy supplies.
- Emergency red flags: sudden massive hemoptysis, acute hypoxemic respiratory failure, or oliguric acute kidney injury — proceed directly to nearest ER; do not delay for outpatient sampling.
Patient FAQ & Clinical Guidance
What is the Goodpasture’s Syndrome Panel and who needs it?
The Goodpasture’s Syndrome Panel detects circulating anti-glomerular basement membrane antibodies, and it is urgently indicated for patients presenting with unexplained hematuria, proteinuria, and hemoptysis to rule out anti‑GBM disease. A positive result, together with clinical and radiological findings, confirms the diagnosis and guides immediate plasmapheresis and immunosuppressive therapy.
يكشف تحليل متلازمة غودباستشر عن الأجسام المضادة للغشاء القاعدي الكبيبي، وهو موجه للمرضى الذين يعانون من بيلة دموية غير مفسرة مع نفث دموي لتأكيد التشخيص وبدء العلاج الفوري.
How is the sample collected and when will I receive my report?
A standard venous blood draw (3 mL serum) is performed at our home collection service, and the specimen is transported in a certified cold chain; when collected by Monday or Wednesday 9 AM, your validated ELISA‑IFA report is ready the next working day. This rapid turnaround accelerates specialist decision‑making and avoids unnecessary delays.
يتم سحب عينة دم وريدي بسيطة (3 مل) عبر خدمة السحب المنزلي، ويتم نقلها بسلسلة تبريد معتمدة، وتصدر النتيجة في يوم العمل التالي عند تسليم العينة قبل التاسعة صباح الإثنين أو الأربعاء.
What does a positive result mean and what are the next steps?
A positive anti‑GBM antibody result, combined with kidney or lung involvement, confirms Goodpasture’s syndrome; the immediate next steps include urgent nephrology/pulmonology referral, hospital admission, and initiation of plasmapheresis and immunosuppression. Serial anti‑GBM titers are then used to monitor treatment response and guide therapy duration.
تعني النتيجة الإيجابية تأكيد تشخيص متلازمة غودباستشر، وتتطلب الإحالة العاجلة إلى أخصائي الكلى أو الصدر وبدء فصل البلازما والعلاج المثبط للمناعة مع متابعة مستويات الأجسام المضادة.
UAE Regulatory Compliance
This service is performed in strict adherence to Federal Decree‑Law No. 41 of 2024 (Art. 87) on medical advertising, the UAE CDS Law 2026 regarding minor consent, and the UAE Personal Data Protection Law (PDPL). All personal health information is encrypted and processed according to DHA/MOHAP data privacy standards. Laboratory facility license: 9834453. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
Sample Collection Mon–Wed 8 AM – 11 PM | Results Next Day
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians